Page Arthur B Vertex Pharmaceuticals Inc Transaction History
Page Arthur B
- $96 Million
- Q1 2024
A detailed history of Page Arthur B transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Page Arthur B holds 716 shares of VRTX stock, worth $335,381. This represents 0.31% of its overall portfolio holdings.
Number of Shares
716Holding current value
$335,381% of portfolio
0.31%Shares
1 transactions
Others Institutions Holding VRTX
# of Institutions
1,826Shares Held
231MCall Options Held
1.49MPut Options Held
1.07M-
Capital World Investors Los Angeles, CA28.5MShares$13.4 Billion2.34% of portfolio
-
Vanguard Group Inc Valley Forge, PA23.5MShares$11 Billion0.21% of portfolio
-
Black Rock Inc. New York, NY21.3MShares$9.98 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA14.5MShares$6.81 Billion1.6% of portfolio
-
State Street Corp Boston, MA11.8MShares$5.52 Billion0.24% of portfolio
About VERTEX PHARMACEUTICALS INC
- Ticker VRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 256,691,008
- Market Cap $120B
- Description
- Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...